SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-043470
Filing Date
2021-02-16
Accepted
2021-02-16 08:01:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d142727dsc13g.htm SC 13G 38641
  Complete submission text file 0001193125-21-043470.txt   40277
Mailing Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210
Business Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210 862160578000
I-Mab (Subject) CIK: 0001778016 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91674 | Film No.: 21632645
SIC: 2834 Pharmaceutical Preparations

Mailing Address 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B BUNDANG-GU, SEONGNAM-SI GYEONGGI-DO M5 13488
Business Address 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B BUNDANG-GU, SEONGNAM-SI GYEONGGI-DO M5 13488 82-31-628-3200
Genexine Inc. (Filed by) CIK: 0001834377 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13G